Business

VOLUNTARY ANNOUNCEMENT A PHASE III CLINICAL TRIAL OF LP-003 FOR THE INDICATION OF SEASONAL AR MET PRIMARY ENDPOINTS

VOLUNTARY ANNOUNCEMENT A PHASE III CLINICAL TRIAL OF LP-003 FOR THE INDICATION OF SEASONAL AR MET PRIMARY ENDPOINTS

articleLongbio Pharma (suzhou) Co., Ltd. Class HJune 11, 20263/news/voluntary-announcement-a-phase-iii-clinical-trial-of-lp-003-for-the-indication-of-seasonal-ar-met-primary-endpoints
VOLUNTARY ANNOUNCEMENT A PHASE III CLINICAL TRIAL OF LP-003 FOR THE INDICATION OF SEASONAL AR MET PRIMARY ENDPOINTS

About this update from Longbio Pharma (suzhou) Co., Ltd. Class H

Longbio Pharma (suzhou) Co., Ltd. Class H (1779) Press ReleaseView Attachment

View stock analysis, news, and events for Longbio Pharma (suzhou) Co., Ltd. Class H